Renal dysfunction among rheumatoid arthritis patients: A retrospective cohort study
Tài liệu tham khảo
Alawneh, 2014, Rheumatoid arthritis in Jordan: a cross sectional study of disease severity and associated comorbidities, Therapeut. Clin. Risk Manag., 10, 363, 10.2147/TCRM.S62954
Widemann, 2006, Understanding and managing methotrexate nephrotoxicity, Oncol., 11, 694, 10.1634/theoncologist.11-6-694
Durando, 2017, Sulfasalazine-induced crystalluria causing severe acute kidney injury, Am. J. Kidney Dis., 70, 869, 10.1053/j.ajkd.2017.05.013
Braun, 2004, Rheumatoid arthritis and the kidney: uneasy companions, Nephron Clin. Pract., 96, c105, 10.1159/000077371
Liu, 2017, Focal segmental glomerulosclerosis lagged behind the onset of rheumatoid arthritis by 7 years: a case report and literature review, Medicine (Baltim.), 96, e5789, 10.1097/MD.0000000000005789
Muthukumar, 2017, Evaluation of renal lesions and clinicopathologic correlation in rheumatoid arthritis, Saudi J. Kidney Dis. Transpl., 28, 44, 10.4103/1319-2442.198118
Pathan, 2004, Rheumatoid arthritis and the kidney, J. Assoc. Phys. India, 52, 488
Agha, 2019, The STROCSS 2019 guideline: strengthening the reporting of cohort studies in surgery, Int. J. Surg., 72, 156, 10.1016/j.ijsu.2019.11.002
Arnett, 1988, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum., 31, 315, 10.1002/art.1780310302
Kasturi, 2014, Comparison of the 1987 American College of Rheumatology and the 2010 American College of Rheumatology/European League against rheumatism criteria for classification of rheumatoid arthritis in the nurses' health study cohorts, Rheumatol. Int., 34, 407, 10.1007/s00296-013-2865-2
Berglin, 2013, Comparison of the 1987 ACR and 2010 ACR/EULAR classification criteria for rheumatoid arthritis in clinical practice: a prospective cohort study, Scand. J. Rheumatol., 42, 362, 10.3109/03009742.2013.776103
Aletaha, 2005, The simplified disease activity index (SDAI) and the clinical disease activity index (CDAI): a review of their usefulness and validity in rheumatoid arthritis, Clin. Exp. Rheumatol., 23, S100
White, 2019, Comparison of the new and traditional CKD-EPI GFR estimation equations with urinary inulin clearance: a study of equation performance, Clin. Chim. Acta, 488, 189, 10.1016/j.cca.2018.11.019
Mori, 2017, Prevalence of and factors associated with renal dysfunction in rheumatoid arthritis patients: a cross-sectional study in community hospitals, Clin. Rheumatol., 36, 2673, 10.1007/s10067-017-3804-5
Gijon-Conde, 2019, Impact of the European and American guidelines on hypertension prevalence, treatment, and cardiometabolic goals, J. Hypertens., 37, 1393, 10.1097/HJH.0000000000002065
Williams, 2018, ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH), Eur. Heart J., 39, 3021, 10.1093/eurheartj/ehy339
Scott, 2010, Rheumatoid arthritis, Lancet, 376, 1094, 10.1016/S0140-6736(10)60826-4
Mittal, 2014, Rheumatological diseases and kidneys: a nephrologist's perspective, Int. J. Rheum. Dis., 17, 834, 10.1111/1756-185X.12424
Boers, 1987, Renal findings in rheumatoid arthritis: clinical aspects of 132 necropsies, Ann. Rheum. Dis., 46, 658, 10.1136/ard.46.9.658
Koivuniemi, 2016, Renal diseases in patients with rheumatoid arthritis, Scand. J. Rheumatol., 45, 432, 10.3109/03009742.2016.1143966
Saisho, 2016, Prevalence of chronic kidney disease and administration of RA-related drugs in patients with RA: the NinJa 2012 study in Japan, Mod. Rheumatol., 26, 331, 10.3109/14397595.2015.1088620
Couderc, 2016, Prevalence of renal impairment in patients with rheumatoid arthritis: results from a cross-sectional multicenter study, Arthritis Care Res., 68, 638, 10.1002/acr.22713
Chiu, 2015, Increased risk of chronic kidney disease in rheumatoid arthritis associated with cardiovascular complications - a national population-based cohort study, PloS One, 10, 10.1371/journal.pone.0136508
Tishko, 2011, Early diagnostics of kidney damage in longstanding rheumatoid arthritis and amyloidosis, Amyloid, 18, 217, 10.3109/13506129.2011.574354081
Sato, 2010, Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis, Scand. J. Rheumatol., 39, 33, 10.3109/03009740903042402
Hayashi, 2010, Elevated level of serum cystatin-C concentration is a useful predictor for myelosuppression induced by methotrexate for treatment of rheumatoid arthritis, Mod. Rheumatol., 20, 548, 10.3109/s10165-010-0315-5
Kapoor, 2018, Renal manifestations of rheumatoid arthritis, Rheum. Dis. Clin. N. Am., 44, 571, 10.1016/j.rdc.2018.06.008
Sumida, 2018, Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease, Kidney Int., 93, 1207, 10.1016/j.kint.2017.11.025
Douville, 2009, Impact of age on glomerular filtration estimates, Nephrol. Dial. Transplant., 24, 97, 10.1093/ndt/gfn473
Stuveling, 2003, C-reactive protein is associated with renal function abnormalities in a non-diabetic population, Kidney Int., 63, 654, 10.1046/j.1523-1755.2003.00762.x
Lipsky, 2000, Infliximab and methotrexate in the treatment of rheumatoid arthritis. anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group, N. Engl. J. Med., 343, 1594, 10.1056/NEJM200011303432202
Nishimoto, 2007, Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab, Ann. Rheum. Dis., 66, 1162, 10.1136/ard.2006.068064
Shinde, 2014, Methotrexate: a gold standard for treatment of rheumatoid arthritis, J. Pain Palliat. Care Pharmacother., 28, 351, 10.3109/15360288.2014.959238
Zhao, 2018, Etanercept for the treatment of rheumatoid arthritis, Immunotherapy, 10, 433, 10.2217/imt-2017-0155
Nakano, 1996, Determination of IgA- and IgM-rheumatoid factors in patients with rheumatoid arthritis with and without nephropathy, Ann. Rheum. Dis., 55, 520, 10.1136/ard.55.8.520